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The development of efficient contrast agents for cell labelling coupled with powerful medical imaging
techniques is of great interest for monitoring cell trafficking with potential clinical applications such
as organ repair and regenerative medicine. In this paper, functionalised multi-walled carbon nanotubes
(MWNTs) were engineered for cell labelling in T1-weighted MRI applications. These sophisticated con-
structs were covalently functionalised with the gadolinium (Gd) chelating agent, diethylene triamine
pentaacetic acid (DTPA), enabling tight attachment of Gd atoms onto the nanotube surface. The resulting
Gd-labelled MWNTs were found to be stable over 2 weeks in water and mouse serum and high payload of
Gd atoms could be loaded onto the nanotubes. The r1 relaxivity of the Gd-MWNTs was a 3-fold higher
than of the clinically approved T1 contrast agent Magnevist at a magnetic field strength of 7T. The con-
trast efficiency, expressed as the r1 relaxivity, of the Gd-MWNTs in Human Umbilical Vein Endothelial
cells (HUVEC) was investigated at 7T and was found to be around 6.6 mM1 s1. There was no reduction
of the contrast efficiency after internalisation in HUVECs, which was imparted to the ability of carbon
nanotubes to translocate the cell membrane.
 2015 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
The ability to combine molecular and cellular imaging using a
single medical imaging technique has attracted significant atten-
tion over the past few decades [1–5]. Examples of such imaging
platforms include Positron Emission Tomography (PET), Magnetic
Resonance Imaging (MRI), X-ray Computed Tomography (CT),
and Single Photon Emission Computed Tomography (SPECT). All
these techniques are non-invasive and enable real time visualiza-
tion of cellular functions of living organisms and related molecular
interactions [6–10]. MRI allows the visualisation of deep tissue,
including soft tissues at high spatial and temporal resolution with-
out the use of external ionising radiation or internal radiotracers,
which makes it a preferable technique for imaging sensitive
organs. While molecular MRI achieves specific imaging of molecu-lar structures, specifically proteins that could be involved in
specific diseases, cellular MRI imaging enables the visualisation
of the whole cell with no discrimination between sub-cell struc-
tures or molecules [11–14].
Nevertheless, the resolution and imaging sensitivity of MRI
relies heavily on the use and performance of metallic contrast
agents. In the case of T1-weighted MRI images, gadolinium (Gd)
based compounds, including chelated complex molecules such as
gadopentetate dimeglumine (Magnevist) have been utilised as
contrast agents pre-clinically for in vitro cell labelling to enable
in vivo tracking and monitoring of stroke lesions or tumour growth
[15–16]. The success and challenge of this technology is closely
correlated to the ability of generating maximum effect on the
relaxation rate of water protons. Although such Gd-based com-
pounds are clinically approved and are widely employed in the
clinical setting, some concerns have been raised due to the possible
toxic side effects from the instability of these complexes in acidic
environments and the release of free Gd3+ [17–18]. Research efforts
have intensified on the development of sophisticated vectors that
could encapsulate high payloads of gadolinium, including lipo-
somes, dendrimers, micelles, carbon nanotubes (CNTs) and
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molar relaxivities [19–20].
Despite recent progress made in using CNTs for diagnostics and
medical imaging, their use in this field remains an important chal-
lenge. For MRI applications, the coupling of CNTs with iron oxide
superparamagnetic nanoparticles have been explored for develop-
ing contrast agents with effect on T2 and T2⁄ relaxation times
[16,21–23]. Several strategies have also been examined for the
development of gadolinium (Gd)-functionalised CNTs as contrast
agents for T1-weighted images [15]. Gadonanotubes [24–25] based
on the nanoscale confinement of significant quantities of gadolin-
ium atoms physically grafted (either onto sidewall defects or at
the open ends) within the carbon backbone of ultra-short single-
walled CNTs, were first reported as T1-MRI contrast agents, fol-
lowed by CNT-Gd oxide complexes and physical adsorption of
Gd3+ chelates onto CNT surfaces [26]. Although these Gd-CNT com-
plexes demonstrated very high r1 relaxativity (relaxation rate
enhancement per millimolar concentration of agents), most of
these entities have not been investigated in an in vivo set-up due
to their poor dispersibility in aqueous media. More recently, oxi-
dised multi-walled carbon nanotubes covalently functionalised
with the Gd3+ chelating agent diethylene triamine pentaacetic acid
(DTPA) were investigated as a means to visualise and monitor the
fate of CNTs in vivo after intravenous injection in small animals
[27]. These Gd-functionalised CNTs were found to display a posi-
tive contrast in T1-weighted images with a relatively high r1 relax-
ivity suitable for tracking CNTs in vivo.
The ability of chemically functionalised carbon nanotubes to
translocate the cell membrane has been described by various
reports and different groups, and is now viewed as an efficient
way to obtain direct access to the cell cytoplasm making them
ideal for cargo delivery into cells [28]. In the case of MRI technol-
ogy, such translocation effect might be of critical importance for
cellular tagging for cell trafficking applications. Indeed the ability
of monitoring transplanted cells in vivo and their tissue distribu-
tion offers critical understanding of cell migration in the body.
The visualisation of successfully implanted cells at the intended
injection site is also very challenging and could be enabled using
cell labelling and MRI technology. In the case of human stem cells
such knowledge is crucial for translation into the clinic for regen-
erative medicine applications.
In recent work, targeted Gd-labelled liposomes were developed
as a cell probe for T1-weighted MR imaging [29]. In this study, Kok
et al. demonstrated that the performance of the endocytosed
gadolinium based liposomes strongly relied on their intracellular
sub-localisation within HUVECs as well as their concentration
and this could impair the in vivo effective relaxation enhancement
of these contrast agents. Therefore, the design of Gd-based
nanoparticles as contrast agents that do not undergo internalisa-
tion into cells by endocytosis pathways was suggested. For thisFig. 1. Preparation of the carbon nanotube constructs for magnetic resonance (MR
functionalization from carboxylated MWNT (1). The latter were then modified into (2) in
onto the amino MWNT by forming an amide bond using peptide chemistry resulting inreason, the use of Gd-CNT constructs as a cell probe for T1-
weighted imaging appears to be a good alternative.
In this study, we describe the development of Gd-functionalised
CNTs as a cell probe for T1-weighted cell tracking MRI applications.
Gadolinium was conjugated to multi-walled carbon nanotubes
(MWNTs) via covalent functionalisation of the nanotube surface
using the chelating molecule DTPA. Gd3+ cations are known to form
very strong complexes with DTPA with a high association constant
leading to very stable Gd-MWNTs conjugates. The Gd-MWNT con-
jugates were characterised using different techniques. The effec-
tive relaxation enhancement was characterised and measured
using T1- and T2-measurements of Gd-MWNT conjugates in water
and the gadolinium content was corroborated with elemental anal-
ysis. The in vitro magnetic resonance relaxivity of the constructs
was investigated in human umbilical vein derived endothelial cells
(HUVECs) as a model cell. Cell viability assays were also performed
in order to assess the possible cytotoxic effects of the Gd-MWNT
constructs.
2. Results and discussion
Multi-walled carbon nanotubes (MWNTs) were used as an engi-
neering platform for designing novel MRI cell probes as they have
demonstrated great ability to delivery drugs and other active sub-
stances to cells [30]. In addition, chemical functionalization of
MWNTs in acidic conditions is known to further enhance their dis-
persibility in aqueous media by adding hydroxyl and carboxyl
groups. In order to investigate the capability of MWNT as efficient
cell probes, MWNTs were functionalised with DTPA. The chemical
attachment of DTPA onto MWNT surfaces was performed by using
a three step process as described in Fig. 1.
Following acid treatment, amine functionalities were added to
MWNT 1 leading to the formation of MWNT 2 using 1,3-dipolar
cycloaddition according to published procedures [31]. Amine
groups are very useful for coupling molecules using a peptide-
like bonding reaction with carboxylic acid groups [31]. MWNT 3
was obtained from MWNT 2 after coupling with DTPA. The func-
tionalised carbon nanotubes MWNT 3 were fully characterised
using standard analytic techniques and were found to display an
approximate loading of 120 lmol g1 of DTPA.
The addition of Gd3+ to the carbon nanotube surface was per-
formed by mixing MWNT 3 with Gd in a large excess in order to
ensure a maximum of DTPA groups conjugated to Gd atoms. The
labelling efficiency of Gd onto MWNT 3 sidewalls, defined as the
ratio between the amount of Gd bound onto the carbon nanotube
sidewall and the initial amount of Gd used for the complexation,
was found to be optimal at 5 equivalents of Gd compared to the
DTPA content (Fig. S1A). However, the maximum concentration
of Gd chelated on MWNT 3 was achieved for 10 equivalents of
Gd. Therefore, in order to maximise the contrast efficiency of the
Gd-MWNT constructs, 10 equivalents of Gd were used for the con-) and fluorescence imaging. Multi-walled carbon nanotube (MWNT) chemical
troducing amino groups via 1,3 dipolar cycloaddition. DTPA ligand was introduced
(3).
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with water using ultracentrifugation. The presence of remaining
free Gd atoms was characterised using xylenol orange. This spec-
trophotometric technique was developed using the property of
xylenol orange to change colour when forming a complex molecule
with free Gd atoms [32]. As a result, the amount of Gd atoms bound
to the DTPA groups on the MWNT surface could be determined and
was found to be around 33.5 lmol g1 which corresponds to a
yield of Gd conjugation of around 28%. In order to assess whether
Gd is bound to MWNT 3 by conjugation to DTPA molecules or by
adsorption onto the graphitic MWNT surface, a control experiment
was performed by mixing MWNT 1 and MWNT 2 with an aqueous
solution of Gd. No significant complexation of Gd3+ with bare
MWNTs was observed implying that the Gd addition to the carbon
nanotube surface was mainly occurring via conjugation with the
chelating agent DTPA. The amount of Gd atoms conjugated to the
DTPA groups of MWNT 3 was confirmed quantitatively by ICP-
MS. The stability of the Gd-MWNT constructs prepared with differ-
ent excesses of Gd in biological media was investigated (Fig. S1B i).
The stability of the Gd-CNT construct with the highest Gd labelling
efficiency was monitored over few days (6 days) by measuring theFig. 2. Characterisation and contrast efficiency of gadolinium-labelled multi-walled car
CNTs (3) with electron microscopy; scanning electron microscopy of carbon nanotube 3 (
(HAADF) scanning transmission electron microscopy (STEM) (iii) of carbon nanotube 3 a
evidenced by the bright spots on the nanotube backbone (black arrows). (Scale bars: 10 n
around 6.6 mM1 s1 (slope of the curve).concentration of free Gd with ICP-MS and xylenol orange spec-
trophotometric technique (Fig. S1B ii). No significant amount of
Gd was detected after 6 days; the release of Gd from the constructs
was measured after 2 weeks in water and mouse serum and no
detectable amount of Gd could be found in the release medium
(data not shown).
In order to assess any structural damage of the sidewall of the
MWNTs due to the chemical functionalization, electron micro-
scopy analyses were conducted using high angle annular dark field
high angle annular dark field (HAADF) scanning transmission elec-
tron microscopy (STEM) and SEM (Fig. 2A).
There was no significant damage on the nanotube sidewalls
using SEM. Using HAADF-STEM, bright dots that were not present
on the unlabelled MWNT 3 could be observed on the walls of
labelled MWNTs indicating the presence of Gd atoms. HAADF-
STEM is known to be a very effective technique enabling visualisa-
tion of heavy-element bearing molecules; intensity of HAADF-
STEM images is directly correlated to the atomic number of the
sample investigated [33–34]. The presence of Gd atoms on Gd-
MWNTs was further confirmed by Energy Dispersive X-ray Spec-
troscopy EDX (Fig. S2).bon nanotubes (Gd-CNTs). (A) Physical characterisation of Gd-CNTs and unlabelled
i) and of Gd-CNTs (ii) (Scale bars: 500 nm and 200 nm); high angle annular dark field
nd (iv) of Gd-CNTs; The presence of gadolinium on the labelled nanotubes could be
m). (B) Determination of the contrast efficiency r1 of Gd-CNTs that was found to be
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images by reducing proton longitudinal relaxation times T1 of pro-
tons in water molecules [35]. The contrast efficiency of the Gd-
MWNT constructs produced was investigated using a 7T MRI
instrument by measuring the longitudinal (T1) and transversal
relaxation (T2) times in water at different Gd-MWNT concentra-
tions (Fig. 2B for T1, and Fig. S3 for T2). The relaxivity that quanti-
fies the contract efficacy of a contrast agent could be determined
by using the relation ri = (Ri  Ri,0)/[Gd] (i = 1,2; Ri = 1/Ti, and Ri,0
is the endogenous relaxation rate). The relaxivity r1 of the Gd-
MWNT constructs was found to be 6.61 s1 mM1. The transverse
relaxivity r2 of the Gd-MWNT constructs was also determined
and was found to be 76.1 s1 mM1 (Fig. S3). Magnevist, Gd-
DTPA, is a clinically approved MR contrast agents and is widely
used in clinical procedures [36]. Magnevist displays a relaxivity
r1 of 2.1 s1 mM1 at 7T, making Gd-MWNTs (6.61 s1 mM1)
three times as efficient as the commercialised low molecular
weight counterpart. The higher performance of the Gd-MWNTs
compared to Magnevist’s was explained by the local environment
sensed by the paramagnetic centre. The high surface area of
MWNTs enables Gd atoms to interact fully with the protons pre-
sent in the medium. Similar results were obtained with other
Gd-CNT constructs where a threefold relaxivity r1 compared to that
of Magnevist was demonstrated [27]. In addition, the Gd-MWNT
constructs seemed to outperform the relaxivity r1 of Gd-
liposomes at similar magnetic field strengths [29]; the greater per-
formance could be explained by the improved interaction of Gd
atoms with protons in water as they are directly exposed to water
molecules being located at the surface of the CNTs. In addition,
local mobility of Gd atoms is known to have an effect on the relax-
ivity. In the case of Gd-MWNTs, Gd atoms are anchored to the nan-
otube surfaces reducing their local mobility; this is beneficial for
the relaxivity as their tumbling rate is lower.
In order to assess the use of the Gd-MWNT constructs as effi-
cient MRI cellular probes, cellular uptake was investigated on
human umbilical vein derived endothelial cells (HUVECs) as a
model of endocytotic cells. The contrast efficiency of Gd-based
contrast agents depends greatly on the accessibility of water mole-
cules to the Gd atoms; steric hindrance around Gd atoms that
reduces its exposure to water protons is known to impair the relax-
ation effect of Gd. Therefore it is crucial to study the local environ-
ment of the Gd-MNWT constructs as well as their organisation in
this environment, their intracellular location and the internalisa-
tion mechanism. HUVECs were selected as a model system as it
has been previously reported that the longitudinal relaxivity r1 of
internalised targeted Gd-liposomes was much lower than non-
targeted Gd-liposomes [29]. It was suggested that this relaxivity
quenching effect for targeted Gd-liposomes was the result of the
construct’s confinement within endosomes, dramatically reducing
Gd exposure to water protons from the bulk of the sample. This
confinement within endosomes was imparted to the mechanism
of internalisation that is different between targeted Gd-
liposomes (internalisation via endocytosis) and non-targeted Gd-
liposomes (non-endocytosis).
Here, HUVEC cells were exposed to different concentrations of
Gd-MWNT constructs (0, 5, 10, 20, 35 or 40 lg ml1) and the cell
viability was investigated at two time points (4 h and 24 h)
(Fig. 3 and Fig. S4).
Unlabelled MWNT 3were used as control. The internalisation of
the carbon nanotubes was monitored over time by optical micro-
scopy (phase contrast vs bright field) and internalisation of mate-
rials was clearly obvious after 24 h with cells turning partly black
(Fig. 3 and S4A and B). Both types of carbon nanotubes (Gd-
MWNT and MWNT 3) seemed to be localised within the cytoplasm
of the HUVECs in a relatively diffused manner around the nucleus
(see bright field images in Fig. 3A and Fig. S4B). The concentrationof Gd internalised in cells after 4 h and 24 h at different Gd-MWNT
concentration was also analysed by ICP-MS (Fig. 3B). The results
demonstrated that internalisation of Gd-MWNT constructs
increased from about 30% (of the initial Gd-MWNT exposing dose)
at 4 h to about 50% at 24 h. Bright field images in Fig. 3A demon-
strated that the amount of CNTs internalised per cell was dose
dependent with a higher CNT content at 20 lg ml1 as compared
to 5 lg ml1 for each type point considered. However, the internal-
isation of Gd-MWNT constructs in each cell pellets measured by
ICP-MS was found to be similar for a considered time point and
independent of the concentration of CNT used (30% after 4 h of
exposure and 50% after 24 h for all three concentrations tested).
After 4 and 24 h of exposure, there was no significant decrease of
cell viability at increasing Gd-MWNT concentrations up to
40 lg ml1 apart from the MWNT 3 at the highest concentration
and after 24 h (Fig. 3C).
To assess the MRI properties of the Gd-labelled cells, HUVEC cell
pellets were produced following incubation of cells with either Gd-
MWNTs or MWNT 3 for 4 h or 24 h (Fig. 4A).
Subsequently, the relaxation rate of the cell pellets were mea-
sured and compared against the control cell pellets without any
carbon nanomaterials (Fig. 4B). The relaxation rate R1 of the
HUVEC-internalised Gd-MWNTs demonstrated a significant con-
trast enhancement of approximately 1.5-fold compared to the
HUVEC-internalised non-labelled MWNT cell pellets (Fig. 4B).
While no difference between an incubation of 4 h and 24 h could
be noticed for the non-labelled MWNTs (MWNT 3), an increase
in R1 could be observed between 4 h and 24 h for the cell pellets
exposed to Gd-MWNT constructs. This was in agreement with
the previous ICP-MS results showing an increase in internalisation
percentage from 4 h to 24 h incubation from 30% to 50%. This led to
an increase in Gd concentration in the cell pellets resulting in a
greater increase in R1. In order to evaluate the efficiency of the
Gd-MWNT constructs as T1-weighted cell probe for MRI, the relax-
ivity that is defined as the slope of the relaxation rate as a function
of Gd concentration was determined (Fig. 4C). HUVECs were incu-
bated with Gd-MWNTs and the non-labelled carbon nanotubes
(MWNT 3) at increasing CNT concentrations (0, 10, 20, 25, 35,
40 lg/ml) for 24 h in order to have a wide range of Gd concentra-
tion inside the cells. The concentration of gadolinium inside the
cell pellets was determined by ICP-MS and was found to range
from 0.002 to 0.04 mM (data not shown). The relaxation rate R1
of the cell pellets were then measured and plotted against Gd con-
centration in order to determine the relaxivity r1 that was found to
be 6.6 s1 mM1 (Fig. 4C). This value of r1 was very similar to that
of Gd-MWNT constructs alone (r1 = 6.61 s1 mM1) and was
almost sixfold higher than the r1 obtained with targeted Gd-
liposomes, when extrapolating the values from the r1 curve [29].
This indicated that there was no r1-reducing effect following inter-
nalisation of the constructs in HUVECs. This represents a signifi-
cant advantage of Gd-labelled MWNTs over other Gd-based
nanoparticles such as liposomes where a dramatic quenching
was observed, that was attributed to subcellular compartmental-
ization of the latter nanomaterials [29].
Several studies have reported the ability of carbon nanotubes to
enter cells via passive diffusion through membranes, known as the
‘needle effect’, suggesting a different mechanism of internalisation
from conventional endocytic pathways [28]. Marangon et al.
demonstrated the use of Gd-labelled carbon nanotubes as efficient
T1-weighted MRI contrast agents in an in vivo set-up [27]. In this
study, it was shown that, although most carbon nanotubes were
gathered in large bundles within vesicular membranes when inter-
nalised in mouse macrophages, a small fraction of isolated tubes
could be identified in the cytoplasm implying a small proportion
of carbon nanotubes internalised by the ‘needle effect’. In our
study, HUVECs were used as a model of cells using endocytosis
Fig. 3. Gd-CNT cell interactions, internalisation and cell viability. (A) Images of HUVEC cells exposed with (i) 20 lg/ml, (ii) 10 lg/ml, (iii) 5 lg/ml, and (iv) 0 lg/ml of Gd-CNTs
for 24 h, scale bar = 100 lm; phase contrast imaging (higher panel) is compared to bright field imaging (lower panel) in which cells not exposed to CNTs have no contrast; (B)
Gd-CNT cell internalisation over time assessed via ICP-MS; Cells were exposed to Gd-CNTs at different concentrations (5, 10, 20 lg/ml) for 4 and 24 h and the concentration of
gadolinium inside cell pellets was measured by ICP-MS; (C) Cell viability of HUVEC cells exposed for 4 and 24 h with non-labelled CNTs and Gd- CNTs (0–40 lg/ml) assessed
with a modified LDH assay.
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Fig. 4. Contrast efficiency of Gd-CNT for cell labelling using MRI. (A) CNT exposed HUVEC cell pellets. HUVEC cells were exposed to Gd-CNTs and non labelled CNTs for (first
two black tubes) 24 h (second two black tubes) at different Gd-CNT concentrations, a control sample of unexposed HUVEC cell pellet (white tube) was also prepared. Prior to
the formation of the pellets, the internalisation of Gd-CNTs was monitored using optical microscopy; (B) MRI characterisation of Gd-CNT internalised HUVEC cells; R1 values
of treated and untreated HUVEC (20 lg l1 of Gd-MWNT construct) cells exposed for 4 and 24 h. (C) Contrast efficiency of Gd-CNTs as new cell probe; R1 values versus
gadolinium concentration (a. 0 lM, b. 4.2 lM; c. 8.1 lM; d. 13.9 lM; e. 20.8 lM; f. 35.5 lM).
A. Servant et al. / CARBON 97 (2016) 126–133 131pathways to internalise molecules and nanoparticles. These cells
were shown to quench the contrast efficiency of targeted Gd-
labelled liposomes after internalisation by endocytosis pathway
[29]. This was explained by the compact confinement of the Gd-
labelled liposomes in intracellular vesicles limiting the exchange
between bulk water protons (which is needed for achieving a
strong T1 relaxation rate enhancement) and gadolinium atoms.
The size and inherently the surface area of these vesicles were
found to be a crucial parameter in the water proton and gadolin-
ium interaction as larger vesicles display smaller surface-to-ratio
limiting an efficient exchange between water protons and gadolin-
ium atoms.
In our study, no quenching was observed after internalisation of
the Gd-labelled MWNT in cells; the same relaxivity value was
indeed obtained in both cell pellets and water (Fig. 4C and
Fig. 2B respectively). This suggested that either a large quantity
of carbon nanotubes did not internalise following endocytosis
pathways or the vesicles in which they are located are small
enough to enable efficient exchange between water protons and
gadolinium atoms. Several studies in our group have confirmedthe tendency of CNTs to internalise by piercing the cell membrane
and subsequently avoiding endosome entrapment [37]. The
absence of endosomal entrapment could explain why no quench-
ing of T1 relaxivity effects was observed with Gd-MWNTs.3. Conclusion
This study demonstrated the great potential of using function-
alised multi-walled carbon nanotubes (MWNTs) as efficient cell
probes for MRI. At the same magnetic field strength, Gd-labelled
MWNTs demonstrated great contrast enhancement in water in
terms of a 3-fold increase in longitudinal relaxivity compared to
Magnevist, the commercially and widely used in clinical proce-
dures MR contrast agent. These sophisticated constructs also
demonstrated great contrast enhancement with a high relaxivity
value of 6.6 s1 mM1 after internalisation in HUVECs similar to
that of the material dispersed in water. Quenching of MRI contrast
agent efficacy in vitro and in vivo is of a great concern as it will
hamper the detection of these agents with MRI. Efficient cell
132 A. Servant et al. / CARBON 97 (2016) 126–133probes and cell labelling are crucial for medical imaging in partic-
ular MRI applications as it could bring a better understanding of
cell interaction and distribution in the human body and potentially
limit the toxicity and side effects involved with Gd-based contrast
agents. These functionalised MWNTs, thanks to their large surface
area allowing higher payload of gadolinium pave the way to a new
generation of Gd-based contrast agents enabling strong contrast
enhancement and potentially reduced toxicity.4. Experimental
4.1. Chemical functionalisation of MWNTs
Starting multi-walled carbon nanotubes (MWNTs) were pur-
chased from Nanostructured and Amorphous Materials Inc. (Hous-
ton, USA) (stock #1240XH: 94% purity, outer diameter 20–30 nm,
length 0.5–2 lm). Starting materials were first oxidised by acid
treatment to generate MWNT 1, then MWNT 2 was obtained by
using 1,3-dipolar cycloaddition reaction as previously reported
[31]. After derivatization with DTPA, MWNT 3 was recovered by
centrifugation, washed with water and re-precipitated from
MeOH/diethyl ether. Kaiser tests confirmed a loading of
0.120 mmol g1 of free amine after DTPA.
4.2. Gadolinium complexation
MWNT 3 were dispersed in water at a concentration of 0.5 mg/
ml. Gadolinium chloride was added to the carbon nanotube solu-
tions at increasing molar equivalents (1, 5, 10, 20, 50, 100,
500 eq.) compared to the evaluated DTPA quantity on the function-
alised carbon nanotubes MWNT 3. The mixtures were allowed to
incubate at room temperature for 1.5 h. The Gd-labelled carbon
nanotubes were then washed three times with water and cen-
trifuged in order to collect them. The quantity of Gd conjugated
to MWNT 3 was determined by monitoring the free gadolinium
during the washing steps using UV–Visible spectroscopy with the
Xylenol Orange assay according to published procedures [32] and
by elemental analysis using ICP-MS (Brucker).
4.3. Gd-labelled carbon nanotube characterisation
The Gd-labelled and unlabelled carbon nanotubes were charac-
terised using HAADF-STEM images and EDX spectra were acquired
on a FEI Tecnai G2 F20 HRTEM operated at 200 kV and equipped
with an EDAX super ultra-thin window (SUTW) X-ray detector.
Samples were deposited on lacey carbon Cu TEM grids (Agar)
and using a high resolution transmission electron microscopy
(HR-TEM), energy dispersive X-ray microscopy (EDX) using a JEOL
ARM 200 F microscope operating at 80 kV.
4.4. MRI characterisation of Gd-labelled carbon nanotubes
All MRI measurements were performed on a 7 T Bruker BioSpec
70/30 USR (Bruker BioSpin MRI GmbH, Etlingen, Germany)
equipped with a 1H 112/072 (outer/inner diameter) circular polar-
ized MRI transceiver volume coil (Bruker BioSpin MRI GmbH, Etlin-
gen, Germany) at room temperature. Eppendorf tubes containing
the carbon nanotube samples in water were placed in a custom
made holder filled with water to facilitate shimming. R1 (1/T1)
measurements were performed with an inversion recovery seg-
mented fast low angle shot (FLASH) sequence, with the following
sequence parameters: TR = 4 ms, TE = 2 ms, FA = 8, inversion time
(TI) from 72.51 to 4792.51 ms in 60 steps, overall scan repetition
time = 15 s, FOV = 40  40 mm2, matrix size = 128  128, slice
thickness = 1 mm and number of averages = 4.R2 (1/T2) measurements were performed using a multi spin-
echo sequence with the following sequence parameters: TR = 2 s,
TE from 8 to 256 ms in 32 steps, FOV = 40  40 mm2, matrix
size = 128  128, slice thickness = 1 mm and number of aver-
ages = 4. The first echo was omitted from data analysis. Longitudi-
nal and transverse relaxation rates were determined using
Mathematica 8.0 (Wolfram Research Inc., Champaign, IL, USA)
and plotted against the gadolinium concentration determined with
ICP-MS. A linear least-squares fit was performed to determine the
longitudinal and transverse relaxivities (mM1 s1) of the MWNTs
according to r1;2 ¼ R
obs
1;2Rdia1;2
½Gd , where r1;2 is the longitudinal or trans-
verse relaxivity (mM1 s1), Robs1;2 (s
-1) is the measured longitudinal
or transverse relaxation rate, Rdia1;2 (s
-1) is the diamagnetic contribu-
tion and [Gd] is the concentration of gadolinium (mM).
4.5. Cell culture
Human HUVECs were purchased from Lonza Bioscience, Basel,
Switzerland (pooled donor, #C2519A). Cells were maintained on
1% gelatin-coated TCPS flasks with 10% FBS completed EGM-2
medium (Lonza Bioscience, Basel, Switzerland) and cultured in a
humidified incubator at 37 C with 5% CO2. The EGM-2 medium
was replaced every 2–3 days. Cells were sub-cultured when reach-
ing 80–90% confluence according to supplier’s instructions.
4.6. Preparation of cell pellets for MRI measurement and ICP-MS
measurement
HUVECs of passage 3 or 4 were used for all experiments. To start
the experiment, medium was replaced by either Gd-labelled or
unlabelled carbon nanotubes containing medium at increasing car-
bon nanotube concentrations (0–40 lg/ml). After incubation for 4
or 24 h, the cells were washed twice with 5 mL of pre-warmed
(37 C) HEPES buffered saline solution (Lonza Bioscience, Basel,
Switzerland). Cells in culture flasks were detached using 2 mL of
0.25% trypsin/1 mM EDTA solution (Lonza Bioscience, Basel,
Switzerland). The trypsin/EDTA solution was neutralized using
4 mL of trypsin neutralizing solution (Lonza Bioscience, Basel,
Switzerland). Cells were then spun down at 1400 rpm for 5 min;
the supernatant was removed, the cell pellet was re-suspended
in 1 ml of 4% PFA in PBS (Gibco, Life technologies) and finally trans-
ferred to a 500 ll Eppendorf tube until the MRI measurements.
For ICP-MS measurement, Gd-MWNT labelled HUVECs were
prepared in a similar fashion. Once collected, cell pellets were re-
suspended in pure nitric acid and boiled overnight to obtain a clear
solution ideal for ICP-MS analysis.
4.7. Magnetic resonance imaging of cell pellets
Eppendorf tubes containing the cell pellets were placed in a
custommade holder filled with water to facilitate shimming. Sagit-
tal slices were planned through the length of the Eppendorf tubes.
R1 (1/T1) and R2 (1/T2) were determined as described for the relax-
ivity measurements, with a FOV of 30  30 mm2. Longitudinal and
transverse relaxation rates were determined in a region of inter-
ested within the cell pellet using Mathematica 8.0 (Wolfram
Research Inc., Champaign, IL, USA). The volume of the cell pellets
was measured using a 3D FLASH sequence, with the following
sequence parameters: TR = 25 ms, TE = 3.7 ms, FA = 30, isotropic
resolution = 0.1 mm, number of averages = 2. The pellet volume
was determined by setting threshold values for the signal intensity
to select the voxels within the cell pellet. The voxels within each
pellet were multiplied by the voxel volume to determine the pellet
volumes. The gadolinium content in each pellet determined by ICP-
A. Servant et al. / CARBON 97 (2016) 126–133 133MSwas divided by the pellet volume to obtain the concentration of
gadoliniumwithin the pellet. Due to a lack of contrast, the volumes
of the naïve cell pellets and the pellets incubated with unlabelled
CNT could not be determined.
4.8. Cytotoxicity
HUVECs were seeded into 96-well plates (5000 cells/well) and
cultured overnight before the experiment in a humidified incuba-
tor (5% CO2, 37 C). Culture medium was removed and replaced
by culture medium containing Gd-labelled and unlabelled carbon
at different carbon nanotube concentrations (0, 5, 10, 20, 40 lg/
ml) nanotubes. HUVECs were incubated for 4 h and 24 h. After
incubation with the carbon nanotubes, the cell viability was mea-
sured using the LDH assay as described in previous published
reports [28].
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